Malaria, caused by parasites of the genus Plasmodium, is one of the leading infectious diseases in many tropical regions, including Nigeria, a West African country where transmission occurs all year round. Many of the inhabitants use plants as remedies against fever and other symptoms of acute malaria, as reported herein. Some of these plants have their antimalarial efficacies scientifically demonstrated and the active compounds isolated with their probable mechanisms of action studied. Medicinal plants are used to treat diseases also where the biodiversity of plants occur in parallel with endemic transmission of malaria. This review focuses on medicinal plants which are used to treat malaria in Nigeria, and on antimalarial testing of extracts and purified compounds from plants. Some show intense activity against malaria parasites in vitro and in experimentally infected mice. The search for new drugs based on plants is important due to the emergence and widespread of chloroquine-resistant and multiple drug-resistant malaria parasites, which require the development of new antimalarials. An acquaintance with antimalarial plants may be a springboard for new phytotherapies that could be affordable to treat malaria, especially among the less privileged native people living in endemic areas of the tropics, mostly at risk of this devastating disease.
Fig. 1. Human malaria distribution in Africa and its estimated burden in Nigeria.
[Adapted from WHO, 2008a , and MARA/AMRA (http://www.mara.org.za)].
common disease in Nigeria; according to the Federal Ministry of Health (2004) , half of its population will have one or more malaria attacks annually.
The continuous spread of Plasmodium falciparum resistance to antimalarial drugs poses a serious threat to malaria control programs. In Nigeria, a nationwide surveillance data on drug efficacy showed that chloroquine (CQ) and sulphadoxine-pyrimethamine (SP) are no longer viable therapeutic options for the effective treatment of human malaria (Federal Ministry of Health, 2004) . Although vaccines could be the best long term control option, they are still undergoing clinical trials (Alonso et al., 2005; Aponte et al., 2007; Bejon et al., 2008; Guinovart et al., 2009 ). This, in addition to the increased number of drug-resistant parasites, makes the development of novel antimalarials urgent. The high cost of malaria treatment has left the poor masses of Nigeria heavily reliant on traditional practitioners and medicinal plants for the treatment of the disease.
Medicinal plants for malaria treatment
Traditional herbal medicines have been used to treat malaria for thousands of years in various parts of the world. The first antimalarial drug used in the Occident was extracted from the bark of the Cinchona (Rubiaceae) species, the alkaloid quinine, still largely used. Infusions of the plant bark were used to treat human malaria as early as 1632 (Baird et al., 1996) . Years later quinine was isolated and characterized (Saxena et al., 2003) , thus becoming the oldest and most important antimalarial drug. Another ancient medicinal plant of millenium use in the West is Artemisia annua, rediscovered in China in the seventies as an important source of the antimalarial artemisinin (Bruce-Chwatt, 1982; Klayman, 1985) . Artemisinin-combined therapies (ACT) were formally adopted as first-line treatment of uncomplicated malaria in Nigeria from 2005 onwards (Mokuolu et al., 2007) . However, ACT use is limited due to its high costs, limited production of artemisinin derivatives to Good Manufacturing Practices (GMP) standards and toxicity (Haynes, 2001; Malomo et al., 2001; Borstnik et al., 2002; Adebayo and Malomo, 2002; Afonso et al., 2006; Boareto et al., 2008) .
Neither the Cinchona plants nor Artemisia annua, from which the most potent drugs (quinine and artemisinin) were isolated, are indigenous to sub-Saharan Africa. Tropical rainforest plants are known to have higher concentrations of natural chemical defenses and a greater diversity than plants from any other biome, thus they are potential sources of new medicines (Balick et al., 1996) . It seems logical then to encourage studies on plants from these regions, especially since the major proportion of malariaattributable deaths occur in sub-Saharan African regions (Fig. 1 ).
The search for new phytochemicals with antimalarial activity
In the last decade, there has been a renewed interest in indigenous medicine worldwide, arising from the realization that orthodox medicine is not widespread. In poor countries, the healthcare is often sustained by other practices based on cultural alternatives. In many developing countries, one-fifth of patients use indigenous herbal remedies to treat malaria (Willcox and Bodeker, 2004) . Although modern medicine may be available in some communities, herbal medicines have often maintained popularity for historical and cultural reasons, in addition to their cheaper costs. The use of plant remedies has steadily increased worldwide in recent years, as well as the search for new phytochemicals that potentially could be developed as useful drugs for the treatment of malaria and other infectious diseases (Willcox, 1999) .
Some decades ago, plants were randomly selected and screened for antimalarial activity. However, this procedure was laborious and did not yield much result. For example, in 1947, crude extracts of 600 species from 126 plant families were screened for their in vivo activity against avian malaria, i.e. Plasmodium gallinaceum in chicks and against Plasmodium cathemerium and Plasmidium lophurae in ducklings (Spencer et al., 1947 ), the available laboratory models then. Active extracts were obtained from species of 33 genera and consistently strong positive results obtained from species of the Simaroubaceae family. A better approach now used is selecting plants based on their ethnobotanical information. Plants are now selected based on their use in indigenous medicine against fever and/or malaria (Carvalho et al., 1991) . This, to a great extent, has reduced the unnecessary waste of time and resources encountered in the former approach.
Nigerian medicinal plants used for malaria treatment
Nigeria has rich flora diversity and many of the plant species are used by some indigenous people for medicinal purposes. A larger number of medicinal plants are used to treat malaria in the Southern part of the country where rain forests exist and originate a humid tropical climate, with ideal conditions for persistent malaria transmission all year round (Fig. 2) . Some plant species are used for malaria treatment across all ethnic and cultural groups in the country, for example, Alstonia boonei (Apocynaceae) and Azadirachta indica (Meliaceae).
A systematic analysis study was carried out through a computer search of data on PubMed and ISI Web of Knowledge using key words (malaria; Nigeria; ethnobotany; antimalarial activity; medicinal plants; plant extracts; active compounds; and mode of action) for articles published from 1984 to 2008. Thus, this review is mainly based on the articles obtained from these databases. The articles selected concern studies on ethnobotany; in vitro and/or in vivo antimalarial activity of plants from Nigeria; isolated antimalarial compounds from these plants; probable mechanisms of action and references from relevant articles. Of the nine ethnobotanical studies in different parts of the country published in these data banks; only two were specifically on medicinal plants used for malaria treatment while the others were on medicinal plants used for various diseases including malaria. Medicinal plants used in Nigeria for malaria treatment are listed in Table 1 .
Alstonia boonei is a high tree of up to 33 m, with a straight and fluted stem, having no buttress roots. The species is highly priced, especially in situations where affordable antimalarial drugs are found ineffective, due to drug-resistant malaria parasites. The plant stem bark or leaves are administered as decoction or "teas" and sometimes as an ingredient in malaria "steam therapy". Recently, the stem bark extract was formulated into tablets, and made available as an antimalarial remedy (Majekodunmi et al., 2008) .
Plants of the Meliaceae family are also commonly used for malaria treatment in Nigeria, like the species Azadirachta indica, Khaya senegalensis and Khaya grandifoliola. Azadirachta indica (Fig. 3) is called "neem tree" and is also used in other African countries as a decoction against fever and/or malaria. It is an evergreen, fast growing tree, up to 25 m in height and is used in traditional medical practice in form of an aqueous decoction of the leaves, stem bark and root . Due to the importance of this plant as an antimalarial remedy in Nigeria, efforts were made to produce the tablet suspensions of the bark and leaf which exhibited high prophylactic, moderate suppressive and a very minimal curative schizonticidal effect in mouse model of malaria (Isah et al., 2003) . Khaya senegalensis and Khaya grandifoliola are often planted by roadsides for shade. The decoctions of their stem barks are extensively used as antimalarial remedies but they seem to have adverse effects (Adebayo et al., 2003; Bumah et al., 2005) . Khaya plants are so widely used for medicinal purposes that it is uncommon to find an intact tree near homes.
Morinda lucida (Rubiaceae), largely used in malaria treatment in Nigeria, is a tree of 9-18 m in height, bearing a dense crown of slender crooked branches (Avwioro et al., 2005) . The wood is moderately coarse, open grained with a tendency to spiral, though not warping nor altering, fairly hard and of medium weight. The aerial parts, stem bark or root bark of Morinda lucida are widely used in West Africa to treat malaria and other tropical diseases. A seasonal variation in its antimalarial activity has been reported (Makinde et al., 1994) . Nauclea latifolia (Rubiaceae) is a small spreading tree, essentially a savannah plant, used as aqueous decoction of the root bark against malaria.
Several other plants are used for malaria treatment in Nigeria, like Quassia amara and Quassia undulata (Simaroubaceae), largely used in the southwestern part of the country (Phillipson and Wright, 1991) . Quassia amara (Fig. 3) , called bitterwood tree, with 2-6 m in height, has the highest antimalarial reputation for curative and preventive purposes in the Simaroubaceae family. Enantia chlorantha (Annonaceae) is an ornamental tree, of up to 30 m in height, with dense foliage and spreading crown. Its stem bark is used against fever/malaria by traditional medicine practitioners in the forest regions. Carica papaya (Caricaceae), commonly referred to as pawpaw, is widely grown in the tropics for its edible fruit and also used as a weak decoction of its leaves against malaria. It is a small tree with a weak soft-wooden stem which is usually unbranched and hollow. Fagara zanthoxyloides (Rutaceae) has its root widely used as chewing stick in Nigeria and West Africa in general (Odebiyi and Sofowora, 1979) . The aqueous extract of the root is used for malaria treatment by the indigenous people. Spathodea campanulata (Bignoniaceae), popularly known as African tulip tree is native to tropical Africa, though it has now been adapted to other tropical regions around the world, mostly because of its ornamental value. It is used in southwestern Nigeria for malaria treatment by drinking the decoction of its stem bark.
Most of these antimalarial plants are used in form of monotherapy, and only a few plants are taken together in combined therapies. An example is the multi-herbal extract referred to as 'Agbo-Iba' made up of Cajanus cajan (pigeon pea) leaf, Euphorbia lateriflora leaf, Mangifera indica leaf and bark, Cassa alata leaf, Cymbopogon giganteus leaf, Nauclea latifolia leaf, and Uvaria chamae bark (Nwabuisi, 2002) . Another multi-herbal combination is the mixture of Carica papaya leaves, Cymbopogon citratus leaves, Anacardium occidentale leaves and Azadirachta indica leaves used in 'steam therapy', in which the patients are covered with a thick blanket and made to inhale the vapour from the cooking pot.
Scientific authentication of antimalarial activities of Nigerian medicinal plants
Pharmacological studies have demonstrated in vitro antiplasmodial and/or in vivo antimalarial activities of extracts from 45 plant species used in Nigerian folk medicine out of the 51 species tested. The publications with respect to both in vivo and in vitro tests herein cited taxonomically identified the plants with certified experts and voucher specimens were deposited in recognized herbaria. Fabricant and Farnsworth (2001) highlighted four standard approaches used for selecting plants: (1) random selection followed by chemical screening, (2) random selection followed by antimicrobial assays, (3) follow-up of antimicrobial activity reports and (4) follow-up of ethnomedical or traditional uses of plants against infectious diseases. Of these four approaches, the follow-up of ethnomedical or traditional uses of plants against malaria was the common approach used by various studies cited in this review. An important factor to consider in the ethnomedical approach is the preparation of extract as described by the traditional healers in order to mimic as much as possible the way the herbal remedy is indigenously used. It was, however, observed that some of the studies did not carry out extraction with the common solvents (e.g. water and ethanol) used for preparation of indigenous medicine. They used solvents such as hexane, methylene chloride, and petroleum ether for extraction Bickii et al., 2000; Goffin et al., 2002; Cimanga et al., 2006) , which are not acceptable in indigenous preparation of plant extracts and this, in a way, could affect the results obtained. All publications with respect to antiplasmodial screening here cited have used classical methodologies such as the continuous culture of Plasmodium falciparum strains (Trager and Jensen, 1976) ; the in vitro antiplasmodial activity tests using radio-isotopic methods (Desjardins et al., 1979) or the microscopic methods; the in vivo antimalarial assays with reference to blood schizonticidal activity of plant extracts called the 4-day suppressive test (Peters, 1965) and Rane (Curative) test similar to that described by Ryley and Peters (1970) , using rodent malaria model. All these approaches of testing plants and their isolated compounds have been recently reviewed (Krettli, 2009; Krettli et al., 2009 ). However, in this review, for in vitro studies, plant extracts considered active have IC 50 values less than 10 g/ml and those partially active with IC 50 values less than 25 g/ml (Carvalho et al., 1991) , while for in vivo studies, extracts were considered active when parasitaemia was reduced at least by 50%.
Some of the active plants are listed in Table 2 . Twenty-four plant species have only been tested in vitro against Plasmodium falciparum and reported to possess antiplasmodial activities. Some a Extracts with IC50 values less than 10 g/ml are considered active while those with IC50 values less than 25 g/ml are considered partially active (Carvalho et al., 1991) . b Many of these plant extracts have not been tested for their cytotoxicities, thus their selectivity indices cannot be calculated. N.S., not specified. of them are: Psidium guajava (Nundkumar and Ojewole, 2002) , Alchornea cordifolia (Banzouzi et al., 2002) , Aspilia africana (Waako et al., 2007) , Cymbopogon citratus (Bidla et al., 2004) , Fagara zanthoxyloides (Kassim et al., 2005) , Sida acuta (Karou et al., 2003) , Khaya senegalensis (El Tahir et al., 1999) , Lippia multiflora (Valentin et al., 1995) , Prosopis africana, Ficus platyphylla, Anogeissus leiocarpus, Ficus thonningii, Cissus populnea, and Terminalia avicennoides (Shuaibu et al., 2008) , Mitragyna inermis (Fiot et al., 2005) , Harungana madagascariensis (Iwalewa et al., 2008) , Vernonia cinerea (Chea et al., 2006) and Nauclea latifolia (Benoit-Vical et al., 1998) . Nauclea latifolia inhibits Plasmodium falciparum erythrocytic cycle mainly at the end of schizogony (32nd to 48th hour) (Benoit-Vical et al., 1998) . It is noteworthy that all the in vitro studies cited in this review used whole organisms, which have been reported to have considerable advantages over the target-oriented options, most especially, they involve all targets and take bioavailability phenomena into account, such as ability of phytochemicals to cross the cell membrane (Cos et al., 2006) . Moreover, most of the in vitro studies used well-characterized drug-sensitive/drug resistant parasite strains. A few authors, like Tona et al. (2004) , however, did not specify the strains of parasite used. Many of the researchers in Nigeria who conducted in vitro studies had to collaborate with other laboratories outside the country. This may partly be as a result of insufficient facilities to support in vitro studies within the country and the high cost of such studies.
Fifteen medicinal plants and one herbal combination only have been screened in vivo for antimalarial activity against Plasmodium berghei or Plasmodium yoelii parasites and reported to be active (Table 3 ). They are: Cylicodiscus gabunensis (Okokon et al., 2006b) , Uvaria chamae and Hippocratea africana (Okokon et al., 2006a) , Enantia chlorantha and Cymbopogon giganteus (Agbaje and Onabanjo, 1991; Kimbi and Fagbenro-Beyioku, 1996) , Cymbopogon citratus and Ocimum gratissimum (Tchoumbougnang et al., 2005) , Cassia singueana (Adzu et al., 2003) , Stachytarpheta cayennensis (Okokon et al., 2008) , Striga hermonthica and Tapinanthus sessilifolius (Okpako and Ajaiyeoba, 2004) , Tetrapleura tetraptera (Okokon et al., 2007b) , Setaria megaphylla (Okokon et al., 2007c) , Phyllanthus amarus (Dapper et al., 2007) , Homalium letestui (Okokon et al., 2006c) and the plant formula 'Agbo-Iba' shown to protect mice against Plasmodium yoelii nigeriensis infection; the herbs used in this formula were decocted for 3 h and then administered to mice orally to evaluate the prophylactic and curative activities. Although the 'Agbo-Iba' formula was prophylactic and had no apparent significant side effects in mice, the formula had no curative activity against established infection (Nwabuisi, 2002) . However, it must be noted that some of the doses used in these in vivo studies may not be of any practical use. For example, the aqueous extracts of Azadirachta indica caused 68% suppression in Plasmodium yoelii nigeriensis-infected mice at a very high dose of 800 mg/kg body weight. The toxicology of such high doses is seldom sufficiently well studied in animal experiments. Moreover, a few studies tested the extracts by intra-peritoneal and sub-cutaneous routes (Ajaiyeoba et al., 1999; Adzu et al., 2003) , and were found efficacious because bioavailability is often better by these routes than by oral route. However, such routes are never used traditionally and results cannot be applied to oral administration. Furthermore, there is a greater risk of toxicity, though such studies reported that the tested extracts were non-toxic in murine model at the doses administered (Ajaiyeoba et al., 1999; Adzu et al., 2003) .
Twelve Nigerian medicinal plants have been reported to exhibit activities in vitro and in vivo include Azadirachta indica MacKinnon et al., 1997; Isah et al., 2003) , Morinda lucida , Khaya grandifoliola Bickii et al., 2000) , Quassia amara (Ajaiyeoba et al., 1999; Bertani et al., 2005) , Guiera senegalensis (Iwalewa et al., 1990; Ancolio et al., 2002) , Tithonia diversifolia (Goffin et al., 2002; Elufioye and Agbedahunsi, 2004) , Vernonia amygdalina (Masaba, 2000; Abosi and Raseroka, 2003) , Cassia occidentalis (Iwalewa et al., 1990; Tona et al., 1999; Zirihi et al., 2005) , Crossopteryx febrifuga Elufioye and Agbedahunsi, 2004) , Spathodea campanulata (Makinde et al., 1988; Dhanabalan et al., 2008) , Momordica balsamina (Benoit-Vical et al., 2006) and Picralima nitida (Okokon et al., 2007a; Iwu and Klayman, 1992) . Azadirachta indica antimalarial activity is attributed to a substantial oxidative stress during malaria infection; it affects all stages of maturation of the gametocytes, unlike artemisinin and primaquine that seem to affect only the immature stages (Dhar et al., 1998) . Picralima nitida possesses a significant in vivo antimalarial activity in both early and established infections (Okokon et al., 2007a) . Recently, we also tested both in vitro and in vivo a variety of Cocos nucifera (mestiç o), used in Middle Belt region of Nigeria as an antimalarial remedy, and found the hexane extract to be active against Plasmodium falciparum W2 clone (an average IC 50 of 10.6 g/ml) and Plasmodium berghei NK65 (reducing parasitemia by 66% and 42% on days 5 and 11 post-infection respectively) (Adebayo et al., 2010) . It should be noted, however, that some of these extracts exhibited very high antimalarial activity in vitro but displayed poor activity in vivo. A good example is Azadirachta indica, which is widely used around the world in indigenous medicine for the treatment of malaria. Its extract exhibited IC 50 ranging from 2.4 to 4.17 g/ml against various strains of Plasmodium falciparum in vitro (Benoit et al., 1996; MacKinnon et al., 1997) , but required very high doses (e.g. 800 mg/kg body weight) to exhibit significant in vivo activity (Isah et al., 2003) . Such high doses are not therapeutically meaningful.
Isolated compounds characterized as antimalarials in Nigerian medicinal plants
The active antimalarial principles of 16 plant species used in Nigerian folkmedicine for malaria treatment have been isolated (compounds considered to be active in this review have IC 50 values of less than 5 g/ml). Among the active compounds isolated (Table 4 , Fig. 4) , majority are alkaloids, followed by limonoids. Many of the isolated compounds have only been tested in vitro against Plasmodium falciparum, probably because of the little quantities isolated. Some of the alkaloids isolated are: (a) fagaronine, a benzophenanthridine alkaloid derived from the root extract of Fagara zanthoxyloides; inhibited Plasmodium falciparum growth in vitro at low IC 50 (0.018 g/ml) (Kassim et al., 2005) ; (b) palmatine and jatrorrhizine, protoberberine alkaloids isolated from Enantia chlorantha (Vennerstrom and Klayman, 1988) ; (c) indole and dihydroindole alkaloids isolated from Picralima nitida, the major constituents including akuammiline, akuammidine, akuammine, akuammigine, akuammicine, picraline, and alstonine (Ansa-Asamoah et al., 1990) . Some of such alkaloids displayed in vitro antimalarial activity against Plasmodium falciparum comparable to chloroquine and quinine (Okunji et al., 2005) , and IC 50 values from 0.01 to 0.9 g/mL, alstonine being the most active.
Limonoids isolated from medicinal plants have also been demonstrated to possess antimalarial activities, for example, gedunin from the wood extracts of Azadirachta indica plants collected in different locations (MacKinnon et al., 1997) . The presence of an ␣, ␤-unsaturated ketone in ring A seems vital for its activity, as well as a 7␣-acetate group; the furan ring also contributed to the described activity. However, gedunin did not inhibit Plasmodium berghei in mice (Bray et al., 1990) . Four other limonoids were isolated from the leaves of Azadirachta indica, of which meldenin was the most active against Plasmodium falciparum (Joshi et al., 1998) . Limonoids active against malaria parasites were isolated from Khaya grandifoliola (methylangolensate, 7-deacetylkhivorin, 1-deacetylkhivorin, and 6-acetylswietenolide and gedunin) (Bickii et al., 2000) . The species Khaya senegalensis (bark, roots and seeds) yielded three limonoids of the mexicanolide type, with fissinolide and its 2,6-dihydroxy derivative exhibiting antiplasmodial activities in vitro (Khalid et al., 1998) .
Other phytochemicals with antiplasmodial activities in Nigerian folkmedicinal plants are: (a) azadirachtin (a tetranortriterpenoid), which occurs in 4-6 g/kg amounts in neem seed kernels (Butterworth and Morgan, 1968) , and inhibits the formation of mobile microgametes in vitro, an activity linked to the presence of a hemiacetal group at C-11 (Jones et al., 1994) ; (b) ursolic acid isolated from the stem bark of Spathodea campanulata, suppressed Not available Elufioye and Agbedahunsi (2004) Extracts considered active reduced parasitaemia by at least 50%. Pb -Plasmodium berghei; Py -Plasmodium yeolii.
infection and prolonged the survival of mice infected with Plasmodium berghei (Amusan et al., 1996) ; (c) anthraquinones from Morinda lucida, the most active being damnacanthal; structure-activity studies showed that an aldehyde group at C-2 and a phenolic hydroxy group at C-3 enhanced activity against Plasmodium falciparum (Koumaglo et al., 1992; Sittie et al., 1999) ; (d) sesquiterpene lactone, Tagitinin C, present in the leaves of Tithonia diversifolia was active against Plasmodium falciparum (Goffin et al., 2002) ; (e) Ajoene, a metabolite of Allium sativum, was active against Plasmodium berghei in mice (Perez et al., 1994) ; (f) Simalikalactone D was identified to be responsible for the antimalarial activity of Quassia amara leaves (Bertani et al., 2006) . However, the possibility that the in vitro data presented in the studies with these phytochemicals could be misleading cannot be overlooked because certain natural products are metabolized and the pharmacokinetics of the individual natural products are often totally ignored. Compounds referred to as being active in vitro may actually be inactive in vivo, e.g. gedunin. It would be extremely helpful if more pharmacokinetic studies could be performed with these phytochemicals, though it must be appreciated that most of the time, small quantities of these compounds are isolated which limits their in vivo studies. Moreover, some of the phytochemicals which have been reported to be active in vivo, exhibited such activities at very high doses that may not be of any meaningful therapeutic use. An example is urosilic acid reported to cause 97.7% chemosuppression in Plasmodium berghei berghei-infected mice but at a dose of 200 mg/kg body weight (Cimanga et al., 2006) . Also, many of these compounds have not been tested for their cytotoxicities. This seriously limits their potentials as future antimalarial drugs. As Gertsch (2009) pointed out, the molecular architecture (carbon scaffold, heteroatoms, functional groups, multiple stereocenters, etc.) of natural products greatly facilitates protein interactions probably because natural products have been phylogenetically selected in a protein environment. Therefore, protein binding interactions of natural products may not be linear with concentration but exponential, implying that high concentrations are always likely to generate a response as multiple proteins are targeted, almost non-selectively. Thus, more data with respect to the cytotoxicities of the phytochemicals are still needed in order to calculate their selectivity indices (cytotoxicity/activity), which will then serve as a strong basis for their being considered as potential antimalarial drugs. Some of these active compounds which have even been tested for cytotoxicity have been found to be toxic, having very low selectivity indices (e.g. tagitinin C and cryptolepine, Table 4 ). All these have brought limitations on some of the isolated compounds being considered as lead molecules for antimalarial drug development.
Mechanisms of action suggested for isolated antimalarial compounds from medicinal plants used in Nigeria
Various mechanisms of action have been postulated for the isolated antimalarial compounds but the mechanisms of action listed below are those obtained from direct study of the compounds on the parasite. The suggested mechanisms of action for some antimalarial compounds isolated from plants are: (i) inhibition of hemozoin polymerization in the parasite, e.g. cryptolepine-an indole alkaloid isolated from Sida acuta and Cryptrolepis sanguinolenta (Banzouzi et al., 2004; Onyeibor et al., 2005; Karou et al., 2007a,b) ; (ii) intercalation with the parasite DNA as in the case of cryptolepine (Kirby et al., 1994) ; (iii) inhibition of Plasmodium falciparum lactate dehydrogenase (pfLDH), an essential enzyme for energy generation within the parasite through glycolysis, e.g. gossypol, a disesquiterpene extracted from seeds of Gossypium species (Royer et al., 1986; Gomez et al., 1997) ; (iv) alkylation e.g. gedunin (Arnason et al., 2004) ; (v) interference with the formation of mitotic spindles and the assembly of microtubules into typical axonemes in gametes, thus inhibiting the formation of mobile micmrogametes e.g. azadirachtin (Jones et al., 1994; Billker et al., 2002) ; (vi) inhibition of proteolytic processing of circumsporozoite protein by a parasite-derived cysteine protease, thereby preventing sporozoite invasion of host cells e.g. allicin, a cysteine protease inhibitor (Coppi et al., 2006) .
Conclusion
The various ethnobotanical surveys carried out in Nigeria have allowed the description of a large number of plants used by the indigenous populations to treat different diseases, especially malaria in the endemic areas of transmission, as herein reviewed. The species investigated for antimalarial activity and their potentials as sources of new antimalarial compounds and new drug leads are herein discussed. Several purified compounds have been isolated and evaluated for their antimalarial activity. Efforts and resources to improve the malaria control programs have increased in Nigeria, where the burden of malaria is greatest in Africa due to the large population. It is in light of these facts that our present studies are directed towards compounds isolated from Nigerian plants with the hope that they will be useful in rolling back this disease. Since malaria is mostly endemic in areas naturally endowed with the rain forests, one hopes that these discoveries of active compounds from plants will generate more effective drugs, affordable and available to the rural people who are mostly at risk of the disease morbidity.
